Steve Albers is Senior Vice President, Market Access and Public
Affairs for Novo Nordisk Inc. since November 2020.
Mr. Albers leads the US Market Access team in setting
strategies and providing national leadership in communicating the
value of all Novo Nordisk products to key payer customers.
Additionally, he directs the Public Affairs team on engagement
with policy makers, educating them on the significance of the
disease states that patients face as well as the business
complexities that Novo Nordisk navigates. Mr. Albers is responsible
for helping ensure that patients who need Novo Nordisk's medicines
are able to get them.
Previously, Mr. Albers was Vice President of Market Access
National Accounts, where he was responsible for payer marketing,
contract strategy, pricing and account management for Novo Nordisk's
portfolio of US medicines. He joined the Executive Team as Corporate
Vice President, Market Access in March 2017.
Mr. Albers has more than 20 years of experience within the
medical and pharmaceutical industries. He joined Novo Nordisk in
2006 as District Business Manager in Minnesota achieving increasing
levels of responsibility in the Sales and Market Access
organization. He spent almost five years in Novo Nordisk's global
headquarters in Denmark as Senior Global Marketing Director for
Market Access before he was appointed Vice President of Global
Prior to joining Novo Nordisk, Mr. Albers was a regional
account manager for Serono Inc., a biotechnology company acquired by
Merck. Before that, he worked at Takeda Pharmaceuticals America in
various sales and account management roles of increasing responsibility.
He holds a bachelor's degree in biology from Concordia College